The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review.
Identifieur interne : 000927 ( PubMed/Corpus ); précédent : 000926; suivant : 000928The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review.
Auteurs : Chirag Shah ; Douglas W. Arthur ; David Wazer ; Atif Khan ; Sheila Ridner ; Frank ViciniSource :
- Cancer medicine [ 2045-7634 ] ; 2016.
English descriptors
- KwdEn :
- MESH :
- diagnosis : Breast Cancer Lymphedema.
- etiology : Breast Cancer Lymphedema.
- prevention & control : Breast Cancer Lymphedema.
- therapy : Breast Cancer Lymphedema.
- Disease Management, Humans, Prospective Studies, Randomized Controlled Trials as Topic, Retrospective Studies.
Abstract
Breast cancer-related lymphedema (BCRL) has become an increasingly important clinical issue as noted by the recent update of the 2015 NCCN breast cancer guidelines which recommends to "educate, monitor, and refer for lymphedema management." The purpose of this review was to examine the literature regarding early detection and management of BCRL in order to (1) better characterize the benefit of proactive surveillance and intervention, (2) clarify the optimal monitoring techniques, and (3) help better define patient groups most likely to benefit from surveillance programs. A Medline search was conducted for the years 1992-2015 to identify articles addressing early detection and management of BCRL. After an initial search, 127 articles were identified, with 13 of these studies focused on early intervention (three randomized (level of evidence 1), four prospective (level of evidence 2-3), six retrospective trials (level of evidence 4)). Data from two, small (n = 185 cases), randomized trials with limited follow-up demonstrated a benefit to early intervention (physiotherapy, manual lymphatic drainage) with regard to reducing the rate of chronic BCRL (>50% reduction) with two additional studies underway (n = 1280). These findings were confirmed by larger prospective and retrospective series. Several studies were identified that demonstrate that newer diagnostic modalities (bioimpedance spectroscopy, perometry) have increased sensitivity allowing for the earlier detection of BCRL. Current data support the development of surveillance programs geared toward the early detection and management of BCRL in part due to newer, more sensitive diagnostic modalities.
DOI: 10.1002/cam4.691
PubMed: 26993371
Links to Exploration step
pubmed:26993371Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review.</title><author><name sortKey="Shah, Chirag" sort="Shah, Chirag" uniqKey="Shah C" first="Chirag" last="Shah">Chirag Shah</name><affiliation><nlm:affiliation>Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.</nlm:affiliation></affiliation></author><author><name sortKey="Arthur, Douglas W" sort="Arthur, Douglas W" uniqKey="Arthur D" first="Douglas W" last="Arthur">Douglas W. Arthur</name><affiliation><nlm:affiliation>Department of Radiation Oncology, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia.</nlm:affiliation></affiliation></author><author><name sortKey="Wazer, David" sort="Wazer, David" uniqKey="Wazer D" first="David" last="Wazer">David Wazer</name><affiliation><nlm:affiliation>Department of Radiation Oncology, Tufts University School of Medicine, Boston, Massachusetts.</nlm:affiliation></affiliation></author><author><name sortKey="Khan, Atif" sort="Khan, Atif" uniqKey="Khan A" first="Atif" last="Khan">Atif Khan</name><affiliation><nlm:affiliation>Department of Radiation Oncology, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey.</nlm:affiliation></affiliation></author><author><name sortKey="Ridner, Sheila" sort="Ridner, Sheila" uniqKey="Ridner S" first="Sheila" last="Ridner">Sheila Ridner</name><affiliation><nlm:affiliation>School of Nursing, Vanderbilt University, Nashville, Tennessee.</nlm:affiliation></affiliation></author><author><name sortKey="Vicini, Frank" sort="Vicini, Frank" uniqKey="Vicini F" first="Frank" last="Vicini">Frank Vicini</name><affiliation><nlm:affiliation>Michigan Healthcare Professionals/21st Century Oncology, Farmington Hills, Michigan.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26993371</idno><idno type="pmid">26993371</idno><idno type="doi">10.1002/cam4.691</idno><idno type="wicri:Area/PubMed/Corpus">000927</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000927</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review.</title><author><name sortKey="Shah, Chirag" sort="Shah, Chirag" uniqKey="Shah C" first="Chirag" last="Shah">Chirag Shah</name><affiliation><nlm:affiliation>Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.</nlm:affiliation></affiliation></author><author><name sortKey="Arthur, Douglas W" sort="Arthur, Douglas W" uniqKey="Arthur D" first="Douglas W" last="Arthur">Douglas W. Arthur</name><affiliation><nlm:affiliation>Department of Radiation Oncology, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia.</nlm:affiliation></affiliation></author><author><name sortKey="Wazer, David" sort="Wazer, David" uniqKey="Wazer D" first="David" last="Wazer">David Wazer</name><affiliation><nlm:affiliation>Department of Radiation Oncology, Tufts University School of Medicine, Boston, Massachusetts.</nlm:affiliation></affiliation></author><author><name sortKey="Khan, Atif" sort="Khan, Atif" uniqKey="Khan A" first="Atif" last="Khan">Atif Khan</name><affiliation><nlm:affiliation>Department of Radiation Oncology, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey.</nlm:affiliation></affiliation></author><author><name sortKey="Ridner, Sheila" sort="Ridner, Sheila" uniqKey="Ridner S" first="Sheila" last="Ridner">Sheila Ridner</name><affiliation><nlm:affiliation>School of Nursing, Vanderbilt University, Nashville, Tennessee.</nlm:affiliation></affiliation></author><author><name sortKey="Vicini, Frank" sort="Vicini, Frank" uniqKey="Vicini F" first="Frank" last="Vicini">Frank Vicini</name><affiliation><nlm:affiliation>Michigan Healthcare Professionals/21st Century Oncology, Farmington Hills, Michigan.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Cancer medicine</title><idno type="eISSN">2045-7634</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast Cancer Lymphedema (diagnosis)</term><term>Breast Cancer Lymphedema (etiology)</term><term>Breast Cancer Lymphedema (prevention & control)</term><term>Breast Cancer Lymphedema (therapy)</term><term>Disease Management</term><term>Humans</term><term>Prospective Studies</term><term>Randomized Controlled Trials as Topic</term><term>Retrospective Studies</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Breast Cancer Lymphedema</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Breast Cancer Lymphedema</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Breast Cancer Lymphedema</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Cancer Lymphedema</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Disease Management</term><term>Humans</term><term>Prospective Studies</term><term>Randomized Controlled Trials as Topic</term><term>Retrospective Studies</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Breast cancer-related lymphedema (BCRL) has become an increasingly important clinical issue as noted by the recent update of the 2015 NCCN breast cancer guidelines which recommends to "educate, monitor, and refer for lymphedema management." The purpose of this review was to examine the literature regarding early detection and management of BCRL in order to (1) better characterize the benefit of proactive surveillance and intervention, (2) clarify the optimal monitoring techniques, and (3) help better define patient groups most likely to benefit from surveillance programs. A Medline search was conducted for the years 1992-2015 to identify articles addressing early detection and management of BCRL. After an initial search, 127 articles were identified, with 13 of these studies focused on early intervention (three randomized (level of evidence 1), four prospective (level of evidence 2-3), six retrospective trials (level of evidence 4)). Data from two, small (n = 185 cases), randomized trials with limited follow-up demonstrated a benefit to early intervention (physiotherapy, manual lymphatic drainage) with regard to reducing the rate of chronic BCRL (>50% reduction) with two additional studies underway (n = 1280). These findings were confirmed by larger prospective and retrospective series. Several studies were identified that demonstrate that newer diagnostic modalities (bioimpedance spectroscopy, perometry) have increased sensitivity allowing for the earlier detection of BCRL. Current data support the development of surveillance programs geared toward the early detection and management of BCRL in part due to newer, more sensitive diagnostic modalities.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26993371</PMID><DateCreated><Year>2016</Year><Month>06</Month><Day>28</Day></DateCreated><DateCompleted><Year>2017</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2045-7634</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Cancer medicine</Title><ISOAbbreviation>Cancer Med</ISOAbbreviation></Journal><ArticleTitle>The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review.</ArticleTitle><Pagination><MedlinePgn>1154-62</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cam4.691</ELocationID><Abstract><AbstractText>Breast cancer-related lymphedema (BCRL) has become an increasingly important clinical issue as noted by the recent update of the 2015 NCCN breast cancer guidelines which recommends to "educate, monitor, and refer for lymphedema management." The purpose of this review was to examine the literature regarding early detection and management of BCRL in order to (1) better characterize the benefit of proactive surveillance and intervention, (2) clarify the optimal monitoring techniques, and (3) help better define patient groups most likely to benefit from surveillance programs. A Medline search was conducted for the years 1992-2015 to identify articles addressing early detection and management of BCRL. After an initial search, 127 articles were identified, with 13 of these studies focused on early intervention (three randomized (level of evidence 1), four prospective (level of evidence 2-3), six retrospective trials (level of evidence 4)). Data from two, small (n = 185 cases), randomized trials with limited follow-up demonstrated a benefit to early intervention (physiotherapy, manual lymphatic drainage) with regard to reducing the rate of chronic BCRL (>50% reduction) with two additional studies underway (n = 1280). These findings were confirmed by larger prospective and retrospective series. Several studies were identified that demonstrate that newer diagnostic modalities (bioimpedance spectroscopy, perometry) have increased sensitivity allowing for the earlier detection of BCRL. Current data support the development of surveillance programs geared toward the early detection and management of BCRL in part due to newer, more sensitive diagnostic modalities.</AbstractText><CopyrightInformation>© 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Chirag</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arthur</LastName><ForeName>Douglas W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wazer</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Tufts University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiation Oncology, Brown University, Providence, Rhode Island.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Atif</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ridner</LastName><ForeName>Sheila</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Nursing, Vanderbilt University, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vicini</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Michigan Healthcare Professionals/21st Century Oncology, Farmington Hills, Michigan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer Med</MedlineTA><NlmUniqueID>101595310</NlmUniqueID><ISSNLinking>2045-7634</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Nov 10;26(32):5213-9</RefSource><PMID Version="1">18838709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 1999 Oct;178(4):311-5</RefSource><PMID Version="1">10587190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2007;46(8):1138-42</RefSource><PMID Version="1">17851861</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2014 Dec;12(4):289-94</RefSource><PMID Version="1">25495384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2005;3(4):208-17</RefSource><PMID Version="1">16379589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2010 Jun;8(2):111-9</RefSource><PMID Version="1">20583873</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2010 Dec;19(6):506-15</RefSource><PMID Version="1">20561790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Breast Cancer. 2012 Apr;12(2):133-7</RefSource><PMID Version="1">22444720</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2008 Jun 15;112(12):2809-19</RefSource><PMID Version="1">18428212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pers Med. 2015 May 20;5(2):153-64</RefSource><PMID Version="1">26011383</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Surg. 2010;8(5):336-41</RefSource><PMID Version="1">20171303</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2012 Aug;19(8):2580-9</RefSource><PMID Version="1">22395997</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PM R. 2011 Dec;3(12):1098-105</RefSource><PMID Version="1">21974905</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2009 Jan-Feb;59(1):8-24</RefSource><PMID Version="1">19147865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2015 May;151(1):121-9</RefSource><PMID Version="1">25850535</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2010 Jan 12;340:b5396</RefSource><PMID Version="1">20068255</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2012 Apr 15;118(8 Suppl):2191-200</RefSource><PMID Version="1">22488693</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2014 Feb;144(1):71-7</RefSource><PMID Version="1">24500108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Phys Ther. 2012 Jan;92(1):152-63</RefSource><PMID Version="1">21921254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1985 Jun 15;1(8442):1387</RefSource><PMID Version="1">2861330</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast J. 2012 May-Jun;18(3):219-25</RefSource><PMID Version="1">22487094</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2001 Mar;34(1):2-11</RefSource><PMID Version="1">11307661</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Surg. 2015 Aug;102(9):1071-8</RefSource><PMID Version="1">26040263</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Phys Med Rehabil. 2009 May;90(5):803-9</RefSource><PMID Version="1">19406300</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2011 Mar;9(1):47-51</RefSource><PMID Version="1">21417767</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1043-7</RefSource><PMID Version="1">7713775</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Phys Med Rehabil. 2008 Jan;87(1):33-8</RefSource><PMID Version="1">17993983</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncologist. 2011;16(10):1367-79</RefSource><PMID Version="1">21964004</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):85-90</RefSource><PMID Version="1">19427748</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Invest. 2010 Jan;28(1):54-62</RefSource><PMID Version="1">19916749</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Support Care Cancer. 2011 May;19(5):703-10</RefSource><PMID Version="1">20467755</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2006 Dec 01;6:273</RefSource><PMID Version="1">17140447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2005 Feb;89(3):221-6</RefSource><PMID Version="1">15754119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Jan 20;27(3):390-7</RefSource><PMID Version="1">19064976</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2010;49(2):166-73</RefSource><PMID Version="1">20100154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Nurs. 2009 Aug;109(8):34-41; quiz 42</RefSource><PMID Version="1">19641404</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Apr 20;27(12):2007-14</RefSource><PMID Version="1">19289624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):565-71</RefSource><PMID Version="1">24411624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Nurs. 2009 Jul;109(7):48-54; quiz 55</RefSource><PMID Version="1">19546644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2013 Dec;46(4):184-92</RefSource><PMID Version="1">25141461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):907-14</RefSource><PMID Version="1">21945108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2002 Sep;75(1):51-64</RefSource><PMID Version="1">12500934</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Phys Med Rehabil. 2014 May;95(5):875-81</RefSource><PMID Version="1">24389401</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2015 Mar;13(1):40-5</RefSource><PMID Version="1">25526543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66</RefSource><PMID Version="1">17237035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Support Care Cancer. 2016 Mar;24(3):1413-9</RefSource><PMID Version="1">26349574</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000072656" MajorTopicYN="N">Breast Cancer Lymphedema</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC4924374</OtherID><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Breast cancer</Keyword><Keyword MajorTopicYN="N">detection</Keyword><Keyword MajorTopicYN="N">intervention</Keyword><Keyword MajorTopicYN="N">lymphedema</Keyword><Keyword MajorTopicYN="N">prevention</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>02</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26993371</ArticleId><ArticleId IdType="doi">10.1002/cam4.691</ArticleId><ArticleId IdType="pmc">PMC4924374</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000927 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000927 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:26993371
|texte= The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26993371" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |